Ovarian cancer: promising results from a combination of immunotherapy
A new immunotherapeutic strategy, combining ipilimumab and nivolumab, gives very promising results in ovarian cancer in the relapse phase.The addition ...
Read moreA new immunotherapeutic strategy, combining ipilimumab and nivolumab, gives very promising results in ovarian cancer in the relapse phase.The addition ...
Read moreVIDEO - Immunotherapies demonstrate unprecedented results in the treatment of advanced cancers. Nicolas Meyer, onco-dermatologist, provides an update on these ...
Read moreNew data, presented at the European Congress of Oncology, confirms the advent of a new therapeutic era in the treatment ...
Read moreThe results presented at the ASCO annual meeting confirm the superiority of immunotherapy over standard chemotherapy in certain lung cancers. ...
Read moreNivolumab (Opdivo®), a cancer immunotherapy, doubles the survival of patients with recurrent head and neck cancer after remission on chemotherapy, ...
Read moreThe search for treatments against virulent forms of melanoma seems promising. Three recent studies highlight the benefits of immunotherapy.Researchers are ...
Read moreAce Mind website (acemind.net) provides you with the latest and accurate medical news, healthcare guides, technology news, technical tutorials, automobiles news, and instructions and knowledge about other fields.
Contact us: khaobanmuang@gmail.com